NCT00105417View on ClinicalTrials.gov

Interluekin-7 to Treat HIV-Infected People Receiving Antiretroviral Treatment

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

May 31, 2006

Conditions
HIV InfectionsHIV
Interventions
DRUG

IL-7

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00105417 - Interluekin-7 to Treat HIV-Infected People Receiving Antiretroviral Treatment | Biotech Hunter | Biotech Hunter